Computational approach to HIV resistance prediction to reverse transcriptase and protease inhibitors

被引：0
|
作者：
Tarasova, O. [1 ]
Mayorov, I. [1 ]
Filimonov, D. [1 ]
Poroikov, V. [1 ]
机构：
[1] VN Orekhovich Inst Biomed Chem, Moscow, Russia
来源：
FEBS OPEN BIO | 2018年 / 8卷
基金：
俄罗斯科学基金会;
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P.22-004-M
引用
收藏
页码：447 / 448
页数：2
相关论文
共 50 条
  • [21] Reverse transcriptase and protease inhibitors mutational viral load in HIV infected pregnant women with transmitted drug resistance in Argentina
    Cecchini, Diego
    Sfalcin, Javier
    Zapiola, Ines
    Gomez, Alan
    Fernandez Giuliano, Silvina
    Mammana, Lilia
    Seravalle, Analia
    Rodriguez, Claudia
    Fay, Fabian
    Belen Bouzas, Maria
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2021, 34 (04) : 371 - 375
  • [22] INHIBITORS OF PROTEASE LOOK BETTER THAN THOSE OF REVERSE-TRANSCRIPTASE FOR HIV IN MAN
    MERIGAN, TC
    SCHAPIRO, J
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 : S168 - S168
  • [23] Vertical transmission of HIV-1 variants resistant to reverse transcriptase and protease inhibitors
    De Jose, MI
    Ramos, JT
    Alvarez, S
    Jimenez, JL
    Muñoz-Fernández, MA
    ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (22) : 2738 - 2739
  • [24] Inhibitors from Natural Products to HIV-1 Reverse Transcriptase, Protease and Integrase
    Jiang, Y.
    Ng, T. B.
    Wang, C. R.
    Zhang, D.
    Cheng, Z. H.
    Liu, Z. K.
    Qiao, W. T.
    Geng, Y. Q.
    Li, N.
    Liu, F.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2010, 10 (14) : 1331 - 1344
  • [25] DEVELOPMENT OF INHIBITORS OF REVERSE-TRANSCRIPTASE AND PROTEASE AS THERAPEUTICS AGAINST HIV-INFECTION
    MITSUYA, H
    JOURNAL OF ENZYME INHIBITION, 1992, 6 (01): : 1 - 8
  • [26] Resistance against reverse transcriptase inhibitors
    O'Brien, WA
    CLINICAL INFECTIOUS DISEASES, 2000, 30 : S185 - S192
  • [27] The HIV protease inhibitors nelfinavir and saquinavir, but not a variety of HIV reverse transcriptase inhibitors, adversely affect human proteasome function
    Piccinini, M
    Rinaudo, MT
    Anselmino, A
    Buccinna, B
    Ramondetti, C
    Dematteis, A
    Ricotti, E
    Palmisano, L
    Mostert, M
    Tovo, PA
    ANTIVIRAL THERAPY, 2005, 10 (02) : 215 - 223
  • [28] Emergence and genetic evolution of HIV-1 variants with mutations conferring resistance to multiple reverse transcriptase and protease inhibitors
    Cabana, M
    Clotet, B
    Martínez, MA
    JOURNAL OF MEDICAL VIROLOGY, 1999, 59 (04) : 480 - 490
  • [29] Comparison of the dynamics of resistance-associated mutations to nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors after cessation of antiretroviral combination therapy
    Wirden, M
    Delaugerre, C
    Marcelin, AG
    Ktorza, N
    Mohand, HA
    Dominguez, S
    Schneider, L
    Ghosn, J
    Pauchard, M
    Costagliola, D
    Katlama, C
    Calvez, V
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (02) : 644 - 647
  • [30] Structure based activity prediction of HIV-1 reverse transcriptase inhibitors
    de Jonge, MR
    Koymans, LMH
    Vinkers, HM
    Daeyaert, FFD
    Heeres, J
    Lewi, PJ
    Janssen, PAJ
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (06) : 2176 - 2183
12345